Bajaj HealthCare Limited

BAJAJHCARE

INE411U01027

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:50 2024-05-06 am EDT			5-day change	1st Jan Change
317 ^INR	-1.60%		-3.07%	-15.66%

Feb. 28	Bajaj Healthcare Bags Contract Manufacturing for APIs from UK, EU Customers; Shares Jump 14%	MT
Feb. 28	Bajaj Healthcare Limited Enters Definitive CDMO Agreement for 15 APIs with UK/EU Customers	CI

Bajaj Healthcare Limited Announces Resignation of Aakashkumar Keshari from the Post of Company Secretary & Compliance Officer Effective

February 03, 2024 at 08:50 am EST

Bajaj HealthCare Limited informed that Mr. Aakashkumar Keshari, has tendered his resignation from the post of Company Secretary & Compliance Officer effective close of business hours of 03rd February, 2024, due to other professional commitments.

Latest news about Bajaj HealthCare Limited

Bajaj Healthcare Bags Contract Manufacturing for APIs from UK, EU Customers; Shares Jump 14%	Feb. 28	MT
Bajaj Healthcare Limited Enters Definitive CDMO Agreement for 15 APIs with UK/EU Customers	Feb. 28	CI
Indian Equities Rebound, Helped by Gains in IT, Auto and Metal Stocks	Feb. 22	MT
Bajaj Healthcare CFO Steps Down	Feb. 11	MT
Bajaj Healthcare Limited Announces Executive Changes	Feb. 09	CI
Bajaj Healthcare Limited Announces Resignation of Rupesh Nikam as Chief Financial Officer	Feb. 09	CI
Bajaj HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 09	CI
Bajaj Healthcare Limited Announces Resignation of Aakashkumar Keshari from the Post of Company Secretary & Compliance Officer Effective	Feb. 03	CI
Bajaj Healthcare Limited Announces Resignation of Avinash K. Dalal as Non-Executive Independent Director	Dec. 26	CI
Bajaj Healthcare Appoints Chief Technical Officer	Nov. 09	MT
Bajaj Healthcare Limited Approves Appointment of Amit Rajan as Chief Technical Officer	Nov. 09	CI
Bajaj HealthCare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
Bajaj Healthcare Commissions Alkaloid Extraction Plant	23-10-18	MT
Bajaj Healthcare Completes Constrution of Alkaloid Extraction Plant in Gujarat, India	23-10-16	MT
Bajaj Healthcare Limited Announces Successfully Completion of Construction of Alkaloid Extraction Plant at Vadodara, Gujarat Unit	23-10-13	CI
Bajaj Healthcare Gets Vadodara, India Unit Inspection Report from US FDA	23-09-13	MT
Bajaj Healthcare Swings to Loss in Fiscal Q1	23-08-16	MT
Bajaj HealthCare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Bajaj HealthCare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-30	CI
Bajaj HealthCare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-30	CI
Bajaj Healthcare Limited Recommends Final Dividend for the Financial Year Ended 31St March, 2023	23-05-30	CI
Bajaj Healthcare Limited Announces Resignation of Luke Fernandez as Non-Executive Independent Director	23-03-16	CI
Bajaj HealthCare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Bajaj Healthcare Unveils New Opium Processing Line in Gujarat, India	22-11-23	MT
Bajaj HealthCare Limited inaugurates New Production Line for Processing of Opium At Savli, Gujarat, India and Commenced the Trial Run for the Same	22-11-23	CI

Chart Bajaj HealthCare Limited

Duration

Period

More charts

Company Profile

Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in activities of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), bulk drugs, branded and generic formulations. Its segments include Bulk Drugs and Formulations. It is focused on development, manufacturing and supply of amino acids, nutritional supplements and API for pharmaceutical, nutraceuticals and food industries. Its APIs include ascorbic acid, CH Base and its derivatives, citicoline sodium, carbamazepine, theobromine, ferrous ascorbate, doxofylline, oxcarbazepine, choline bitartrate and its derivatives, octenidine dihydrochloride, vildagliptin, ticagrelor, diosmin, hesperidin and others. Its FDFs include Cellin 500, Septran DS Tablet, Vitajaj C tables 500mg, Ticajaj 90 tablets, Ecojaj 75mg & 150mg, Deferajaj 400mg & 500mg, Vildajaj 50mg and Vildajaj M 50/500. It also offers Inositol Nicotinate and Magnesium L-Threonate.

Sector

Pharmaceuticals

Calendar

2024-05-27 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BAJAJ HEALTHCARE LIMITED	-15.66%	107M
ELI LILLY AND COMPANY	+28.50%	662B
NOVO NORDISK A/S	+22.23%	546B
JOHNSON & JOHNSON	-4.93%	359B
MERCK & CO., INC.	+16.97%	323B
ABBVIE INC.	+4.08%	289B
ASTRAZENECA PLC	+13.68%	234B
NOVARTIS AG	+3.84%	198B
ROCHE HOLDING AG	-10.35%	194B
AMGEN INC.	+3.98%	167B

Other Pharmaceuticals